TIL Instil Bio Inc.

USD 11.10 0.09 0.817439
Icon

Instil Bio Inc. (TIL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 11.10

+0.09 (+0.82)%

USD 0.08B

8.60K

USD 18.00(+62.16%)

USD 2.50 (-77.48%)

Icon

TIL

Instil Bio Inc. (USD)
COMMON STOCK | NSD
USD 11.10
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.08B

USD 2.50 (-77.48%)

USD 11.10

Instil Bio Inc. (TIL) Stock Forecast

Show ratings and price targets of :
USD 18.00
(+62.16%)

Based on the Instil Bio Inc. stock forecast from 1 analysts, the average analyst target price for Instil Bio Inc. is USD 18.00 over the next 12 months. Instil Bio Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Instil Bio Inc. is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Instil Bio Inc.’s stock price was USD 11.10. Instil Bio Inc.’s stock price has changed by -9.09% over the past week, -5.77% over the past month and -10.08% over the last year.

No recent analyst target price found for Instil Bio Inc.
No recent average analyst rating found for Instil Bio Inc.

Company Overview Instil Bio Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecul...Read More

https://instilbio.com

3963 Maple Avenue, Dallas, TX, United States, 75219

192

December

USD

USA

Adjusted Closing Price for Instil Bio Inc. (TIL)

Loading...

Unadjusted Closing Price for Instil Bio Inc. (TIL)

Loading...

Share Trading Volume for Instil Bio Inc. Shares

Loading...

Compare Performance of Instil Bio Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for TIL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Instil Bio Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing TIL

Symbol Name TIL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Instil Bio Inc. (TIL) Stock

Based on ratings from 1 analysts Instil Bio Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on TIL's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for TIL is USD 18.00 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 18.

TIL stock's Price/Earning ratio is 7.94. Our analysis grades TIL stock's Price / Earning ratio at F. This means that TIL stock's Price/Earning ratio is above 52% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TIL may be a overvalued for its sector.

The last closing price of TIL's stock was USD 11.10.

The most recent market capitalization for TIL is USD 0.08B.

Based on targets from 1 analysts, the average taret price for TIL is projected at USD 18.00 over the next 12 months. This means that TIL's stock price may go up by +62.16% over the next 12 months.

We can't find any ETFs which contains Instil Bio Inc.'s stock.

As per our most recent records Instil Bio Inc. has 192 Employees.

Instil Bio Inc.'s registered address is 3963 Maple Avenue, Dallas, TX, United States, 75219. You can get more information about it from Instil Bio Inc.'s website at https://instilbio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...